Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China, Japan Sign Agreement to Share Marrow Donation Information (China)

This article was originally published in PharmAsia News

Executive Summary

The Chinese Marrow Donor Program (CDMP) has partnered with Japan's bone marrow bank as of Sept. 25. The two organizations are dedicated to pooling their resources in an effort to find more cell donors for leukemia patients. China's database currently contains 670,000 donors while Japan's boasts 280,000. By combining, both groups hope to significantly increase the chances of finding hematopoietic stem cells that match those of leukemia patients. Currently, China has over one million leukemia patients, a number that is growing by about 40,000 people annually. Japan also has over 2,000 patients awaiting hematopoietic stem cells. The CDMP has already created similar alliances with the U.S., South Korea, and Singapore, and donated 11 sets of stem cells to patients in those countries. (Click here for more - May Require Free Registration

Latest Headlines
See All
UsernamePublicRestriction

Register

SC065674

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel